• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FINELINE II EZ STEROX; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FINELINE II EZ STEROX; IMPLANTABLE LEAD Back to Search Results
Model Number 4470
Device Problems Fracture (1260); Use of Device Problem (1670); Defective Device (2588); Contamination /Decontamination Problem (2895)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/18/2024
Event Type  Injury  
Event Description
It was reported that this right atrial (ra) lead was explanted due to lead fracture.During the replacement procedure, it was noted that the ra lead insulation was damaged and filled with blood, possibly due to a suture being tied down on the lead instead of the suture sleeve at implant.The ra lead was successfully replaced with a new lead.No additional adverse patient effects were reported.The ra lead is expected to return for analysis.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, visual inspection revealed a cut in the insulation and blood/body fluid in the lumen(s).This type of damage is consistent with induced damage.In this case, we believe the damage occurred during lead implant due to the suture being tied down on the lead and not on a suture sleeve.The reported blood and body fluid in the lead is likely the result of the lead damage observed by the laboratory.
 
Event Description
It was reported that this right atrial (ra) lead was explanted due to lead fracture.During the replacement procedure, it was noted that the ra lead insulation was damaged and filled with blood, possibly due to a suture being tied down on the lead instead of the suture sleeve at implant.The ra lead was successfully replaced with a new lead.No additional adverse patient effects were reported.The ra lead is expected to return for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FINELINE II EZ STEROX
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key18662250
MDR Text Key334799033
Report Number2124215-2024-06991
Device Sequence Number1
Product Code DTB
UDI-Device Identifier00802526264993
UDI-Public00802526264993
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P960004/S014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/07/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/06/2024
Device Model Number4470
Device Catalogue Number4470
Device Lot Number875536
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/11/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/06/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age73 YR
Patient SexMale
-
-